a public good project by the
Synthesis
Company
of California

© 2026

Matthew A. Firpo | doi.page

0 works0 citations0 h-index

Matthew A. Firpo

University of Utah(US)Huntsman Cancer Institute(US)

Publications by Year

Research Areas

Pancreatic and Hepatic Oncology Research, Cancer Genomics and Diagnostics, Cholangiocarcinoma and Gallbladder Cancer Studies, Pancreatitis Pathology and Treatment, Cancer Immunotherapy and Biomarkers

Most-Cited Works

→ Phenotype and Genotype of Pancreatic Cancer Cell Lines(2010)933 cited
→ Stat3 and MMP7 Contribute to Pancreatic Ductal Adenocarcinoma Initiation and Progression(2011)522 cited
→ The Clinical Utility of CA 19-9 in Pancreatic Adenocarcinoma: Diagnostic and Prognostic Updates(2013)355 cited
→ Heparin-regulated release of growth factors in vitro and angiogenic response in vivo to implanted hyaluronan hydrogels containing VEGF and bFGF(2006)315 cited
→ Early Detection of Sporadic Pancreatic Cancer(2015)291 cited
→ Screening for Pancreatic Cancer(2012)246 cited

→ Inverse association between adiposity and telomere length: The fels longitudinal study(2010)

219 cited

→ Release factor RF-3 GTPase activity acts in disassembly of the ribosome termination complex(1998)191 cited

→ The chromatin regulator Brg1 suppresses formation of intraductal papillary mucinous neoplasm and pancreatic ductal adenocarcinoma(2014)187 cited

→ Exosomes harbor B cell targets in pancreatic adenocarcinoma and exert decoy function against complement-mediated cytotoxicity(2019)180 cited